NLS Collaboration

Collaboration - May 10, 2021

Glooko collaborates with Eli Lilly

Glooko has announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen and Tempo Smart Button (currently in late-stage […]

Agreement - May 5, 2021

Alligator Bioscience and BioArctic collaborate

The two companies have entered into a joint research agreement. Under the agreement, Alligator will employ its antibody generation technologies in collaboration with BioArctic to develop new product candidates, it states in a press release. “We are very pleased that BioArctic has recognized the power of Alligator’s proprietary phage display libraries which have been successfully […]

Collaboration - May 3, 2021

WASP and DDLS collaborate

The Wallenberg AI, Autonomous Systems and Software Program (WASP) and the SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS), will initiate a collaboration. The ultimate goal of the collaboration will be to solve ground breaking research questions and to create synergies across disciplines. The effort will bring together state-of-the-art research infrastructures, research networks […]

Collaboration - April 22, 2021

Nanoform and Aprecia enter collaboration

The two companies are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies, they state in a press release. The immediate product innovation target for the collaboration is to combine Nanoform’s fast […]

Clinical Trials - April 20, 2021

Novo Nordisk expands collaboration with Gilead

Gilead Sciences and Novo Nordisk have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). The companies will conduct a phase 2b double-blind, placebo-controlled study to investigate the safety and efficacy of Novo Nordisk’s semaglutide, a GLP-1 receptor agonist, and a fixed-dose combination of Gilead’s investigational FXR agonist cilofexor and investigational ACC inhibitor firsocostat, alone and […]

Collaboration - April 19, 2021

Meet our Nordic life science stars 2021!

As an example of the versatility of the Nordic life science industry we have chosen to highlight five Nordic stars in our latest issue of the magazine. The five companies are at different stages of development, with different focus areas, from different Nordic countries, and they represent the different strongholds that the region possesses. One […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.